Acoustic Pulse Technology
Improving the female reproductive system
19% of couples fail to get pregnant after one year of trying (infertility)*
In 1/3 of the cases the origin of the fertility problem is in the woman and in 1/3 the origin is unknown.
* women aged 18 to 49 with no prior births, In the United States
Insufficient thickness in the Endometrium (< 7 mm) is considered as a major cause for embryo absorption difficulties .
Acoustic Pulse Technology (APT) is used to treat various inflammatory disorders. - such as wound healing, erectile dysfunction and heart ischemia.
Latica-Med Ltd. uses its innovative acoustic pulses technology (APT) to prepare women for the delicate IVF process, by treating most of the root-causes of infertility, including: Infections, implantation failures, endometrium thickness and Endometriosis.
The APT biologic mode of operation is scientifically proven for:
The company:
Latica-Med Ltd., a Medical devices company, focused on developing novel therapies designed to transform the standard of care for Gynecology and other diseases with the aim to improve women fertility, Menopause, Vestibulitis, Endometriosis, Cervicitis, Urinary Incontinence by non-invasive, non-drug therapy.
Technology:
Latica owns a proprietary patented Acoustic Pulse Technology (APT) device specifically designed for treating Gynecology disorders. APT as a shockwave have been widely reported over the last 20 years for treating patients with inflammatory, ischemic diseases treatment devices. Latica's APT is a compact, cost-effective device, specially designed for treatments on a large treatment area (50x350 mm), which can open an opportunity for Gynecology treatments in a short time.
Co-Founder, CEO/CTO Technology inventor, medical devices professional, 25-year experience CEO, R&D and Operation. Including R&D manager at Medispec Ltd – a shockwaves systems vendor and General Electric. B.Sc. in electronics and computer science
Dr. Sagiv - Board Member possesses extensive expertise spanning more than 18 years in diverse domains of pharmaceutical and medical devices development, encompassing preclinical and clinical studies, regulatory affairs, and intellectual property. Currently serving as the VP of Research and Development at Gynica, a medical company dedicated to investigating and advancing cannabinoid solutions tailored to address gynecological symptoms and diseases.
Prof. Slomo Mashiah - Advisory board chair One of the world’s leaders and pioneers in IVF. Former chief of dept. of Ob&Gynat Sheba Medical Center and president of the Association for the Fertility Study. Director of the IVF department (The largest in Israel ) at “Assuta” Medical Center, Tel Aviv. During the 35 years of Prof. Mashiah published hundreds of papers and has helped infertile couples to reproduce tens of thousands of children.
R&D and product management VP at hi-tech/device/ biotech companies, including DirexLtd. – a shockwaves systems vendor, Orbotech-AOI & OMS. UrogenPharma… BSc (Electrical Engineering – Technion). MSc studies (BIU), MBA studies (TAU). Part of Israel Security Prize project team.
DACH Region Alliance.
MBA, International Strategic Alliance.
One of the world’s leaders and pioneers in IVF. Former chief of dept. of Ob&Gynat Sheba Medical Center and president of the Association for the Fertility Study.
Improving a female reproductive system by Acoustic Pulses Therapy .
HaTa'as Street 20; Kefar Sava, Israel; Erzherzog Karl Straße131-135/8/119 1220 Wien Austria
Open today | 09:00 – 17:00 |
Copyright © 2024 Latica - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.